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Purpose: 
Fast Field Cycling (FFC) MRI is able to switch between magnetic fields during the application of a 
pulse sequence. In this way it is potentially able to exploit the different T1 dispersion behaviour of 
tissue and contrast agents to optimise contrast between normal and pathological tissues. In 
particular, FFC-MRI allows access to a new contrast mechanism known as ΔR1 imaging in which 
contrast depends on the change in R1 between different fields [1]. In this work, a proof-of-principle 
study has been carried out using contrast agents designed specifically for use with FFC-MRI which 
show large changes in R1 between different magnetic fields. These contrast agents are detected 
with much greater sensitivity in a ΔR1 image compared with standard T1 weighted images. 
Materials and Methods: 
A new contrast agent consisting of Mn[II] ions surrounded by POPC:PEG (95:5) liposomes diluted 
in a HEPES buffer solution was designed for use with FFC-MRI. The solution was first diluted to 
five different concentrations; A: 0.15 mM, B: 0.1 mM, C: 0.08 mM, D: 0.06 mM, and E: 0.04 mM 
respectively. Sample F containing 1.0 mM CuSO4 was also prepared in de-ionised water in order 
to provide comparison with the Mn[II] contrast agent, as CuSO4 unlike Mn[II] shows almost no 
change in R1 between field strengths. The samples were imaged using a home-built, whole-body 
FFC-MRI scanner with detection at B0 = 58.7 mT (2.499 MHz) [2].  
Results: 
T1 weighted images were acquired 
initially at 58.7 mT with evolution times of 
10 ms, 100 ms, 220 ms, 330 ms, 440 ms 
and 600 ms (Figure 1A, images (i – vi) 
respectively). The images were then 
acquired at 2 mT using the same 
evolution times. Using these data, maps 
of R1 values were calculated using a 
program written in MATLAB (MathWorks, 
MA, USA), for each pixel in a set of 
images. R1 maps at 59 mT and 2 mT 
were then subtracted to give a ΔR1 value 
for each pixel. Figure 1B shows a ΔR1 
map for each of the samples (A – F) in 
the imaging phantom. Figure 2 shows the 
ratio between the image intensities of the 
Mn[II] samples and the CuSO4 sample, 
comparing the ΔR1 values to T1 weighted 
images at 2 mT, and at 59 mT. 
Conclusions:     
The FFC-MRI ΔR1 mapping technique 
takes advantage of the R1 dispersion of 
the Mn[II] liposomal contrast agent, resulting in higher contrast between the Mn[II] and the 1.0 mM 
CuSO4 samples compared with T1 weighted imaging. Typically normal tissue exhibits only a small 
change in R1 between 2.5 and 10 MHz [3], and as such, ΔR1 mapping could be used to enhance 
contrast between regions containing contrast agent and surrounding areas of normal tissue.  
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